Clyde Hill, WA, United States of America

Andreas Caduff

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Amazon Technologies, Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Caduff. Retrieved from https://idiyas.com/inventor/andreas-caduff-q7ewrxp9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Andreas Caduff

Introduction: Andreas Caduff is a pioneering inventor based in Clyde Hill, WA (US) known for his groundbreaking contributions to the field of medical technology.

Latest Patents: Andreas Caduff holds several patents in the medical device industry, with his most recent inventions focusing on non-invasive monitoring technologies for healthcare applications.

Career Highlights: With a career spanning over two decades, Andreas Caduff has established himself as a leading figure in the development of cutting-edge medical devices aimed at improving patient care and outcomes.

Collaborations: Throughout his career, Andreas Caduff has collaborated with top research institutions, universities, and medical professionals to bring his innovative ideas to life and make a lasting impact on the healthcare industry.

Conclusion: Andreas Caduff's dedication to innovation and his relentless pursuit of excellence continue to drive advancements in medical technology, making him a respected figure in the field of inventors and patent holders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…